APA (7th ed.) Citation

Golay, J., Cuppini, L., Leoni, F., Micò, C., Barbui, V., Domenghini, M., . . . Rambaldi, A. (2007). The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells. Leukemia (08876924), 21(9), 1892. https://doi.org/10.1038/sj.leu.2404860

Chicago Style (17th ed.) Citation

Golay, J., et al. "The Histone Deacetylase Inhibitor ITF2357 Has Anti-leukemic Activity in Vitro and in Vivo and Inhibits IL-6 and VEGF Production by Stromal Cells." Leukemia (08876924) 21, no. 9 (2007): 1892. https://doi.org/10.1038/sj.leu.2404860.

MLA (9th ed.) Citation

Golay, J., et al. "The Histone Deacetylase Inhibitor ITF2357 Has Anti-leukemic Activity in Vitro and in Vivo and Inhibits IL-6 and VEGF Production by Stromal Cells." Leukemia (08876924), vol. 21, no. 9, 2007, p. 1892, https://doi.org/10.1038/sj.leu.2404860.